Antares Pharma (ATRS) announced that its loss in the fourth-quarter increased to $5 million, or 4 cents per share, versus a loss of $154,000, or less than one cent per share in the final quarter of 2011, when it had fewer shares outstanding. Revenue increased by one percent to $5.5 million.